World's Best Scientists 2026 revealed!
Iacopo Olivotto

Iacopo Olivotto

D-Index & Metrics

Medicine

D-Index
92
Citations
41423
World Ranking
11124
National Ranking
404

Iacopo Olivotto publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Iacopo Olivotto sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 716 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Iacopo Olivotto D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Iacopo Olivotto sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 92 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Iacopo Olivotto is affiliated with the University of Florence in Italy and focuses their research on cardiology and cardiovascular medicine. Their body of work spans multiple topics related to heart diseases, particularly cardiomyopathies and the molecular mechanisms underlying these conditions.

Their recent notable publications include:

  • 2023 ESC Guidelines for the management of cardiomyopathies (2023, European Heart Journal)
  • Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial (2020, The Lancet)
  • Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic Cardiomyopathy (2020, Circulation)
  • Cardiac Involvement in Fabry Disease (2021, Journal of the American College of Cardiology)
  • Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis (2023, Nature Reviews Rheumatology)

Their frequent co-authors reflect a collaborative approach within cardiovascular research and include:

  • Anjali Owens
  • Francesco Cappelli
  • Sara Saberi
  • Daniel Jacoby
  • Carlo Fumagalli

Olivotto has published in a variety of journals, with repeated contributions to several prominent venues such as:

  • European Heart Journal (52 publications)
  • Circulation (32 publications)
  • International Journal of Cardiology (28 publications)
  • Journal of the American College of Cardiology (25 publications)
  • European Heart Journal Supplements (17 publications)

Their domain expertise lies broadly within medicine, with a strong sub-specialization in cardiology and cardiovascular medicine. Other documented subfields include molecular biology, epidemiology, surgery, and physiology.

The main research topics focus on:

  • Cardiomyopathy and Myosin Studies
  • Cardiovascular Function and Risk Factors
  • Cardiovascular Effects of Exercise
  • Cardiac pacing and defibrillation studies
  • Viral Infections and Immunology Research
  • Congenital Heart Disease Studies
  • Cardiac electrophysiology and arrhythmias

Best Publications

  • Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy

    Martin S. Maron;Iacopo Olivotto;Sandro Betocchi;Susan A. Casey

  • Short-Term Clinical Outcome of Patients With Acute Pulmonary Embolism, Normal Blood Pressure, and Echocardiographic Right Ventricular Dysfunction

    Stefano Grifoni;Iacopo Olivotto;Paolo Cecchini;Filippo Pieralli

  • Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction

    Martin S. Maron;Iacopo Olivotto;Andrey G. Zenovich;Mark S. Link

  • Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

    Iacopo Olivotto;Artur Oreziak;Roberto Barriales-Villa;Theodore P. Abraham

  • Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population.

    Barry J. Maron;Iacopo Olivotto;Paolo Spirito;Susan A. Casey

  • Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy

    Raymond H. Chan;Barry J. Maron;Iacopo Olivotto;Michael J. Pencina

  • Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy

    Iacopo Olivotto;Franco Cecchi;Susan A. Casey;Alberto Dolara

  • Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy.

    Franco Cecchi;Iacopo Olivotto;Roberto Gistri;Roberto Lorenzoni

  • Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy.

    Steve R. Ommen;Barry J. Maron;Iacopo Olivotto;Martin S. Maron

  • Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine

    Barry J. Maron;Steve R. Ommen;Christopher Semsarian;Paolo Spirito

  • Genotype and lifetime burden of disease in hypertrophic cardiomyopathy insights from the sarcomeric human cardiomyopathy registry (SHaRe)

    Carolyn Y. Ho;Sharlene M. Day;Euan A. Ashley;Michelle Michels

  • Hypertrophic Cardiomyopathy Phenotype Revisited After 50 Years With Cardiovascular Magnetic Resonance

    Martin S. Maron;Barry J. Maron;Caitlin Harrigan;Jacki Buros

  • Mitral Valve Abnormalities Identified by Cardiovascular Magnetic Resonance Represent a Primary Phenotypic Expression of Hypertrophic Cardiomyopathy

    Martin S. Maron;Iacopo Olivotto;Caitlin Harrigan;Evan Appelbaum

  • Gender-Related Differences in the Clinical Presentation and Outcome of Hypertrophic Cardiomyopathy

    Iacopo Olivotto;Martin S. Maron;A. Selcuk Adabag;Susan A. Casey

  • Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy

    Barry J Maron;Iacopo Olivotto;Pietro Bellone;Maria Rosa Conte

  • Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC)

    Antonio Pelliccia;Erik Ekker Solberg;Michael Papadakis;Paolo Emilio Adami

  • Late Sodium Current Inhibition Reverses Electromechanical Dysfunction in Human Hypertrophic Cardiomyopathy

    Raffaele Coppini;Cecilia Ferrantini;Lina Yao;Peidong Fan

  • Myofilament Protein Gene Mutation Screening and Outcome of Patients With Hypertrophic Cardiomyopathy

    Iacopo Olivotto;Francesca Girolami;Michael J. Ackerman;Stefano Nistri

  • Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study

    Derralynn A Hughes;Kathleen Nicholls;Suma P Shankar;Gere Sunder-Plassmann

  • Hypertrophic cardiomyopathy in tuscany: Clinical course and outcome in an unselected regional population

    Franco Cecchi;Iacopo Olivotto;Alessio Montereggi;Gennaro Santoro

Frequent Co-Authors

Barry J. Maron
Barry J. Maron University of Massachusetts Chan Medical School
Martin S. Maron
Martin S. Maron Tufts University
Magdi H. Yacoub
Magdi H. Yacoub Imperial College London
Euan A. Ashley
Euan A. Ashley Stanford University
Christopher Semsarian
Christopher Semsarian University of Sydney
Steven D. Colan
Steven D. Colan Boston Children's Hospital
Paolo G. Camici
Paolo G. Camici Vita-Salute San Raffaele University
Perry M. Elliott
Perry M. Elliott University College London
Claudio Rapezzi
Claudio Rapezzi University of Ferrara
Alexandre C. Pereira
Alexandre C. Pereira Universidade de São Paulo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a future in Medicine or healthcare, there are several flexible online degree options worth exploring. For those focused on the growing field of nutrition and wellness, the best online nutrition degree programs can open doors to careers in dietetics or nutrition science.

Aspiring healthcare administrators may benefit from degrees at institutions recognized for their standards, such as cahme accredited online Master of Healthcare Administration (MHA) programs. This accreditation ensures quality and greater job market acceptance.

Nursing professionals who want to advance their qualifications can consider online rn to bsn programs without clinical requirements for more flexibility and less time spent away from work. For those seeking a terminal nursing degree in the fastest timeframe, explore a 1 year dnp program online to push your career to the highest clinical or leadership levels.

Online degrees can be especially helpful for working students and professionals looking to boost their credentials or specialize within healthcare. Each of these pathways can complement or serve as alternatives to traditional medical studies in the USA.

Best Scientists Citing Iacopo Olivotto

Trending Scientists

Recently Published Articles